The Australian shares declined on Thursday, 10 December 2020, with benchmark indices snapping seven straight sessions of winning streak, as investors opted to secure recent gains after the market's recent rise, with geopolitical tensions with China, concerns over a long-awaited U. S. stimulus package, and eyes on upcoming events in Europe adding to a risk-off mood.
At closing bell, the benchmark S&P/ASX200 dropped 45.35 points, or 0.67%, to 6,683.12. The broader All Ordinaries fell 48.25 points, or 0.69%, to 6,917.14.
The market was ripe for taking profits following a weak lead from Wall Street overnight after disappointment over the halting progress of economic US stimulus talks. Meanwhile, concerns over stalled talks in the United States on its delayed stimulus package to address the economic fallout from the coronavirus pandemic, which has battered the U. S. economy, also saw investors taking profits.
Tensions between Australia and China escalated further after Beijing said it would temporarily impose anti-subsidy fees on some Australian wine imports from Dec. 11.
Investors were also closely eyeing a number of upcoming events in Europe, including UK-EU trade talks, with British Prime Minister Boris Johnson and the European Union's chief executive agreeing to conclude talks on a new trade pact by the end of the week, and the European Central Bank's policy meeting.
Today, losses were widespread with every sector lower.
Leading the falls were the healthcare, IT and communications sectors which all fell roughly 1% or more. The financials and utilities outperformed, experiencing narrower declines.
Gold stocks fell the most, following a steep sell-off in bullion prices on Wednesday, as a breakthrough in U. S. fiscal stimulus negotiations remained elusive.
Shares of travel-related firms such as Qantas Airways and Sydney Airport Holdings declined after UK and U. S. health regulators issued allergy warning on Pfizer's COVID-19 vaccine.
Appen (APX) fell sharply with the AI firm sliding 12.4% on a trading update. APX downgraded its FY20 guidance on weaker than expected revenue in Q4 due to COVID-19 lockdowns in California, impacting its major customers. FY underlying EBITDA is now expected between $106-109 million from $125-130 million.
CURRENCY NEWS: The Aussie dollar remains well supported by strong commodity prices, particularly iron ore, and holds at 74.66 US cents.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU